U.S. federal trademark · Serial No. 90031603 · Reg. No. 6512549
pharmaceutical preparations for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; drugs for medical purposes, namely, anticancer drugs; biological preparations for medical purposes for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; medicines for human purposes for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; Biochemical medicines for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; Antibody drug for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; multispecific antibody for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; multispecific antibody format for treatment of cancer, infectious disease, metabolic disease, central nervous system disease; medicines for veterinary purposes for treatment of canine disease; biological preparations for veterinary purposes for treatment of canine disease
Product development for others; pharmaceutical drug development services; scientific research and development; pharmaceutical research; research and development of new products; Consulting services in the field of pharmaceutical technology development; Biochemical research and analysis; Biomedical research services; development of pharmaceutical preparations and medicines; Research and development of antibodies
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.